Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device

Istanbul University150 enrolled

Overview

This randomized trial is determining the role of antibiotic prophylaxis in the prevention of the infectious complications in patients carrying out totally implantable venous access device.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

150

Conditions

Solid Tumor

Interventions

cefazolin SodiumDRUG

cefazolin Sodium 1g i.v. before operation

placeboDRUG

placebo

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Older than 18 years of age * Have solid tumor * White cells \>4000 * Platelets \>100.000 * Prothrombin time in normal range Exclusion Criteria: * Drug allergy * Diabetes mellitus

Locations (1)

Istanbul University Institute of Oncology

Istanbul, Capa, Turkey (Türkiye)

Outcomes

Primary Outcomes

infectious complication

Time frame: 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.